Arkolith/Insider Trading/MAIA/Form 4

Himmelreich Jeffrey C

Head of FinanceMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed Feb 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2025Grant(A)10K—$010K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-25-004347) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML